Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Gebruik van DOAC’s met 15% gestegen
okt 2022 | Benigne hematologie, Hartfalen, Neuro-vasculair